50% off Premium Yearly

NYSE:G
This summary was created by AI, based on 3 opinions in the last 12 months.
Genpact Ltd (G-N) is a growth-focused company, particularly in banking and insurance services, showcasing a commendable earnings growth of 13% over the past 15 years. Despite its solid performance metrics, including a PE ratio of 9.7x and a free cash flow yield of 8.5%, investor sentiment has waned, with the stock experiencing a 20% decline this year due to unfounded fears surrounding AI. Recent insights from analysts suggest a more cautious approach towards the stock, as it has recently triggered a stop-loss at $43 and is currently deemed stagnating. Experts recommend covering positions to maintain discipline, reflecting a need for strategic reassessment in light of current market conditions.
Genpact Ltd is a American stock, trading under the symbol G (previously G-N on Stockchase) on the New York Stock Exchange (G). It is usually referred to as NYSE:G or G
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on G (previously G-N on Stockchase). 3 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Genpact Ltd.
Genpact Ltd was recommended as a Top Pick by Brendan Caldwell on 2002-07-02. Read the latest stock experts ratings for Genpact Ltd.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Genpact Ltd.
Genpact Ltd is covered by Stockchase experts and is worth watching.
On 2026-06-17, Genpact Ltd (G) stock closed at a price of $31.48.